Correspondence 0001013762-23-003249 from Pheton Holdings Ltd (PTHL) (CIK 0001970544) (ITOC)
Pheton Holdings Ltd (PTHL) (CIK 0001970544)
Date: Oct. 11, 2023 · CIK: 0001970544 · Accession: 0001013762-23-003249
AI Filing Summary & Sentiment
Referenced dates: September 25, 2023
Show Raw Text
CORRESP
1
filename1.htm
Pheton Holdings Ltd
October 11, 2023
Via EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
Office of Industrial Applications & Services
100 F Street, NE
Washington, D.C. 20549
Re:
Pheton Holdings Ltd
Draft Registration Statement on Form F-1/A
Submitted September 6, 2023
CIK No. 0001970544
Ladies and Gentlemen:
This letter is in response to the letter dated
September 25, 2023, from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”)
addressed to Pheton Holdings Ltd (the “Company,” “we,” and “our”) regarding the above-mentioned Draft
Registration Statement on Form F-1/A (“Amendment No. 2”). For ease of reference, we have recited the Commission’s comments
in this response and numbered them accordingly. The Registration Statement on Form F-1 (“Registration Statement”) is being
filed to accompany this letter. Capitalized terms used but not defined in this letter have the meanings ascribed to such terms in Registration
Statement.
Draft Registration Statement on Form F-1/A, submitted September
6, 2023
Cover Page
1. We note your revisions in response to prior
comment 1. We reissue in part. Please disclose on the cover page that Mr. Jianfei Zhang, through ZJW (BVI) Ltd, is the sole holder of
all issued and outstanding Class B ordinary shares.
Response: In response to the Staff’s
comment, we have included the requested disclosure on the cover page of the Registration Statement.
2. Revise to disclose whether any transfers,
dividends, or distributions have been made to date between the holding company and your subsidiaries, or to investors, and quantify the
amounts where applicable.
Response: In response to the Staff’s
comment, we have revised our disclosures on the cover page, and pages 5 and 6 of the Registration Statement.
Prospectus Summary
Summary of Risk Factors, page 6
3. We note your revisions in response to prior
comment 9. We reissue in part. Please expand your disclosures here to disclose that the rules and regulations in China can change quickly
with little advance notice, and that there is risk the Chinese government may intervene or influence your operations at any time.
Response: In response to the Staff’s comment, we have
further revised our disclosures on the page 6 of the Registration Statement.
Risk Factors
Beijing Feitian faces the risk of fluctuations in the cost, availability,
and quality of supplies...., page 37
4. We note your revisions in response to prior comment 14. We note
your disclosure that your annual purchases are attributed to one or two suppliers. Please provide the names of those principal suppliers.
For guidance, consider Item 4 to Form 20-F and Form F-1.
Response: We respectfully advise the Staff
that we have disclosed the names of our principal suppliers on page 101 of the Registration Statement. To enhance clarity of the disclosure,
we have revised our statements on page 101 to specify that these suppliers individually contributed to more than 10% of the total annul
purchases, and updated the cross-reference on page 37 of the Registration Statement.
Capitalization, page 60
5. We note your response to comment 17. It remains unclear what
the difference is between the 2nd and 3rd bullet especially given that you are only presenting one pro forma as adjusted column. Please
revise as necessary.
Response: In response to the Staff’s
comment, we have revised our disclosures on page 60 of the Registration Statement.
Market Trends and Opportunities, page 77
6. We note your response to prior comment 24. Your market disclosures
provide information for the entire medical device market in China. To provide context for the information, please include balancing disclosure
by discussing your addressable market.
Response: In response to the Staff’s
comment, we have revised our disclosures on pages 80, 82, 83 and 87 of the Registration Statement regarding industrial information and
data, as well as disclosures on pages from 91 to 93 of the Registration Statement regarding our analysis of market trends and opportunities.
Business
Manufacturing and Supply
Service Fulfillment, page 100
7. We note your disclosure here that 93% of
customers with CD-ROM-Equipped computers selected the backup option of having a burned CD. We also note your disclosure on page F-10 stating
“The FTTPS sales contracts are primarily on a fixed price basis, which require the Company to provide core software, a set of hardware
as peripherals to operate the software, and related services, including transportation, packaging, installation and training based on
customers’ specific needs.” Please clarify whether there are significant differences to the purchase price of the sales contract
depending on the selection of a burned CD as a backup option. In addition, please disclose how many of your customers have CD-ROM-equipped
computers.
Response: In response to the Staff’s
comment, we have revised our disclosures on page 100 of the Registration Statement. We respectfully advise the Staff that the backup option
we offer to customers with CD-ROM equipped computers is a complimentary service with no additional cost, and such selection does not significant
affect the purchase price of the sales contract.
General
8. We note the changes you made to your disclosure
appearing on the cover page, Summary and Risk Factor sections relating to legal and operational risks associated with operating in China
and PRC regulations. It is unclear to us that there have been changes in the regulatory environment in the PRC since the prior amendment
that was confidentially submitted on July 7, 2023, warranting revised disclosure to mitigate the challenges you face and related disclosures.
The Sample Letters to China-Based Companies sought specific disclosure relating to the risk that the PRC government may intervene in or
influence your operations at any time, or may exert control over operations of your business, which could result in a material change
in your operations and/or the value of the securities you are registering for sale. We remind you that, pursuant to federal securities
rules, the term “control”
(including the terms “controlling,”
“controlled by,” and “under
common control with”) as defined in Securities Act Rule 405 means
“the possession, direct or indirect, of the power to direct or cause
the direction of the management and policies of a person, whether through the ownership of voting securities, by contract, or otherwise.”
The Sample Letters also sought specific disclosures relating to uncertainties regarding the enforcement of laws and that the rules and
regulations in China can change quickly with little advance notice. We note that you have removed references to the PRC government’s
power to exert substantial influence over the conduct of your business, the fact that the regulations to which you are subject may change
rapidly and with little notice, and the level of government involvement in the Chinese economy. We do not believe that your revised disclosure
referencing the PRC government’s intent to reinforce its regulatory
oversight conveys the same risk. Please restore your disclosures in these areas to the disclosures as they existed in your confidential
submission as of July 7, 2023.
Response: In response to the Staff’s
comment, we have restored certain disclosures on the cover page, pages 1, 5, 8, 15, 16, 17, 23, 25, 28 and 29 of the Registration Statement.
We appreciate the assistance the Staff has provided
with its comments. If you have any questions, please do not hesitate to contact our counsel, Ying Li, Esq., of Hunter Taubman Fischer&
Li LLC, at yli@htflawyers.com.
Very truly yours,
/s/ Jianfei Zhang
Name:
Jianfei Zhang
Title:
Chief Executive Officer and Chairman of the Board of Directors
cc:
Nudrat Salik, Terence O’Brien, Nicholas O’Leary
and Lauren Nguyen, Securities and Exchange Commission Ying Li, Esq., Hunter Taubman Fischer & Li LLC